Navigation Links
New Australian Technology: Detecting Breast Cancer With Hair
Date:6/19/2008

linical studies focussed on improving the accuracy of the test in conjunction with current screening technologies. This strategy will enable Fermiscan to understand the expectations of local clinicians, patients and regulatory bodies, as well as developing relationships with local clinics for distribution of the Test when appropriate.

The recently announced acquisition of Sydney Breast Clinic, one of Australia's leading providers of diagnostic services for breast cancer, has a strategic fit that aligns the objectives of both groups to improve health outcomes for women. Sydney Breast Clinic was a major participant in Fermiscan's successful 2,000 patient trial. The continued collaboration with the Sydney Breast Clinic will significantly help the development and future commercialisation of the Fermiscan Test.

References

(1) Berg W, et al. Combining screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA 2008; 299(18):2151-63.

(2) Fermiscan validation trial (2,000 patients) May 2008

(3) American Cancer Society 2007 (Cancer Facts and Figures 2007) and http://www.nbcc.org.au

(4) Time The Changing Face of Breast Cancer 15 October 2007

(5) James V, Kearsley J, Irving T, Amemiya Y, Cookson D. Using hair to screen for breast cancer. Nature 1999;398:33-34.

(6) Meyer P, James VJ. Experimental confirmation of a distinctive diffraction pattern in the hair from women with breast cancer. J Natl Cancer Inst 2001;93(11):873-875.

(7) James V, Corino G, Robertson T, Dutton N, Halas D, Boyd A, Bentel J, Papadimitriou J. Early diagnosis of breast cancer by hair diffraction. Int J Cancer 2005;114:969-972.

(8) Corino G, French P. Diagnosis of breast cancer by X-ray diffraction of hair. Int J Cancer 2008; 122:847-856.

Media Contacts

Susan Fitzpatrick


SOURCE Fermiscan
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Kibow Biotech Obtains Australian, Chinese and Indian Patents Protecting the Composition and Basic Technology Behind Its Oral Probiotic Formulation for Chronic Kidney Failure
2. Vermillions Biomarkers Prove Beneficial in Identifying Women With Ovarian Cancer and Detecting Early-Stage Disease
3. Bionovo Elucidates Mechanism of Breast Cancer Control by Estrogen Receptor Beta
4. Bionovo Discovers New Estrogen Regulatory Elements for Breast Cancer and Osteoporosis Drugs
5. Legacy Good Samaritan Hospital Surgeons Find BSGI Effective in Determining Extent of Breast Cancer in Patients With Known Diagnosis
6. Kosans Lead Hsp90 Inhibitor, Tanespimycin, Shows High Level of Activity in Trastuzumab Resistant/Refractory HER2-Positive Breast Cancer in a Phase 2 Trial
7. Further Clinical Testing of BZL101 in Advanced Breast Cancer Demonstrates Favorable Efficacy and Toxicity Profiles
8. Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments
9. Karmanos Cancer Institute Researchers Show Phase I Immunotherapy with Armed T Cells Improve Overall Survival of Metastatic Breast Cancer Patients
10. Study Finds Disparities in Breast Cancer Treatment Even Among Fully-Insured African-American and Caucasian Women
11. Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... VIENNA, Va. , Nov. 21, 2014  Alta ... in Southern California , today announced ... technology. Alta will be providing the innovative BeClose system ... Logo - http://photos.prnewswire.com/prnh/20141121/160143LOGO ... providing the kind of affordable 24/7 care our clients ...
(Date:11/21/2014)... MARCOS, Texas , Nov. 21, 2014  World ... hemp containing low THC, announces they are now offering ... comparable to Charlotte,s Web type strains grown in medical ... from other neurological disorders, such as Parkinson,s, MS, and ... for US laws to pass, because imported CBD Oil ...
(Date:11/21/2014)... , 21. November 2014 ... heute bekannt gegeben, dass die Europäische ... die Kennzeichnung als Orphan-Medizinprodukt an Palovarotene ... Unternehmens zur Behandlung von Fibrodysplasia ossificans ... stark beeinträchtigende genetische Krankheit, die von ...
Breaking Medicine Technology:Alta Home Care, Inc. and BeClose Partner to Enable Seniors to Remain in Their Homes Safely and Securely 2New CBD Oil From Industrial Hemp is Comparable to Charlotte's Web, Legal In All 50 States 2New CBD Oil From Industrial Hemp is Comparable to Charlotte's Web, Legal In All 50 States 3Clementia Pharmaceuticals erhält EMA-Kennzeichnung als Orphan-Medizin für Palovarotene zur Behandlung von Fibrodysplasia ossificans progressiva 2Clementia Pharmaceuticals erhält EMA-Kennzeichnung als Orphan-Medizin für Palovarotene zur Behandlung von Fibrodysplasia ossificans progressiva 3
... Ga., Sept. 14, 2011 Greenway Medical Technologies, ... Inland Northwest Health Services (INHS) today announced an ... health record (EHR) and practice management solution ... practices requiring advanced care coordination and network interoperability. ...
... 14, 2011 Delcath Systems, Inc. (NASDAQ: ... sponsored an industry symposium at the Cardiovascular ... in Munich, Germany—the largest international forum for minimally ... radiologists in attendance. The event, held ...
Cached Medicine Technology:Greenway Partners With INHS to Advance EHR Adoption 2Greenway Partners With INHS to Advance EHR Adoption 3Delcath Systems, Inc. Hosts Symposium on Chemosaturation at CIRSE Annual Meeting 2Delcath Systems, Inc. Hosts Symposium on Chemosaturation at CIRSE Annual Meeting 3
(Date:11/23/2014)... The clinical trial report, "Aspergillosis Global ... the Aspergillosis clinical trial scenario. This report provides ... trials on Aspergillosis. It includes an overview of ... per the site of trial conduction across the ... disease clinical trials by their phase, trial status, ...
(Date:11/23/2014)... 23, 2014 The report, “Market ... to 2020 - Asia-Pacific” provides quantitative analysis of ... segments: minimally invasive body contouring devices, non-invasive body ... includes market size data by revenue and volume ... countries: China, Japan, South Korea, Australia and India. ...
(Date:11/23/2014)... 23, 2014 Nearly 260 testosterone ... strokes, deep vein thrombosis and other serious cardiovascular ... multidistrict litigation (MDL) underway in the Northern District ... Court documents updated on November 17th by the ... the filing of 259 lawsuits against the makers ...
(Date:11/23/2014)... Locks-Magnetic.com, a notable magnetic locks maker, has released ... products are available at low rates up to 30% ... the new emergency doors. The emergency door adopts fireproof ... from several colors. All of the products are top-quality ... is not as easy as many people think. ...
(Date:11/23/2014)... SWAccessControl.com's high quality access control power suppliers are ... announced its new collection of power suppliers. Additionally, it ... power suppliers. All the new models come with big ... until Dec. 20, 2014. , SWAccessControl.com has thousands of ... it for a long time. It is very wise ...
Breaking Medicine News(10 mins):Health News:Aspergillosis Pipeline and Clinical Trials Market (Compnies and Drugs) Review H2 2014 Report at ReportsnReports.com 2Health News:Aspergillosis Pipeline and Clinical Trials Market (Compnies and Drugs) Review H2 2014 Report at ReportsnReports.com 3Health News:Aspergillosis Pipeline and Clinical Trials Market (Compnies and Drugs) Review H2 2014 Report at ReportsnReports.com 4Health News:Aesthetic Lasers and Energy Devices Market in APAC (China, Japan, South Korea, Australia and India) to 2020 2Health News:Aesthetic Lasers and Energy Devices Market in APAC (China, Japan, South Korea, Australia and India) to 2020 3Health News:Aesthetic Lasers and Energy Devices Market in APAC (China, Japan, South Korea, Australia and India) to 2020 4Health News:Testosterone Lawsuits Approach 260 in Illinois Federal Court Litigation, Bernstein Liebhard LLP Reports 2Health News:Testosterone Lawsuits Approach 260 in Illinois Federal Court Litigation, Bernstein Liebhard LLP Reports 3Health News:Cheap Access Control Power Supplies Online Now at SWAccessControl.com, Special Offer Until Dec. 20, 2014 2
... Make Breast Cancer ... Nov. 8 Washington State has the highest rate,of breast ... of Susan G. Komen for the Cure will host a ... policymakers to increase the budget for,screening programs for low-income women ...
... and OXFORD, England, November 8 /PRNewswire-FirstCall/,-- Evotec AG (Frankfurt Stock Exchange: ... on Tuesday, 13 November 2007. The Company is going to ... details: Date: Tuesday, 13 November 2007 Time: 02.00 p.m. ... 08.00 a.m. US time ...
... Nov. 8 World Diabetes Day, November 14,is observed ... 160 countries,and by others with an interest in diabetes. ... provides an excellent opportunity,to focus on the significant increase ... response. Funded by the National Institutes of Health ...
... Nov. 8 Repligen Corporation,(Nasdaq: RGEN ) today ... ended September 30, 2007. Total revenue for the quarter ... fiscal year,2007 ended September 30, 2006, an increase of ... of Protein A product revenue.,Gross profit on product revenue ...
... Healthcare professionals can now conduct immediate comprehensive general, health diagnosis ... ... than ever., UNION CITY, ... products company manufacturing point-of-care,blood analysis systems, announced today that the U.S. ...
... Nov. 8 Thoratec,Corporation initiated a worldwide ... Ventricular Assist Devices (IVAD) having Catalogue No.,10012-2555-001, ... and,distributed since October 2004. The current Instructions ... in the pre-peritoneal (internal) position or placed,in ...
Cached Medicine News:Health News:Puget Sound Komen for the Cure, Former First Lady Mona Locke, Washington Health Leaders and Breast Cancer Survivors Call for Action to Reduce State's High Breast Cancer Incidence 2Health News:World Diabetes Day Spotlights Type 1 Diabetes Increase and World Class Response 2Health News:World Diabetes Day Spotlights Type 1 Diabetes Increase and World Class Response 3Health News:Repligen Reports Second Quarter Fiscal Year 2008 Financial Results 2Health News:Repligen Reports Second Quarter Fiscal Year 2008 Financial Results 3Health News:Repligen Reports Second Quarter Fiscal Year 2008 Financial Results 4Health News:Repligen Reports Second Quarter Fiscal Year 2008 Financial Results 5Health News:Repligen Reports Second Quarter Fiscal Year 2008 Financial Results 6Health News:Repligen Reports Second Quarter Fiscal Year 2008 Financial Results 7Health News:Abaxis Announces First Ever CLIA-Waived Comprehensive Metabolic Panel 2Health News:Abaxis Announces First Ever CLIA-Waived Comprehensive Metabolic Panel 3Health News:Abaxis Announces First Ever CLIA-Waived Comprehensive Metabolic Panel 4Health News:URGENT Thoratec Corporation Worldwide Recall of Implantable Ventricular Assist Device 2
... Stereo Cube is used to diagnose Stereo and ... use of polarized glasses. The test can ... stereopsis, visual attention, form and depth perception. The ... to 450 seconds of arc and is ideal ...
The Lang Stereotest was created to simplify stereopsis screening in children. It is based on two principles: random dots and cylindrical gratings. The Lang Stereotest I measures disparities: Star 600...
... test was developed to test for both crossed ... the more reliable red/green glasses to provide ... dependent on polarizing spectacles which can be quite ... attractive image of a butterfly which makes the ...
... to assist patients with red-green color deficiencies in ... off wavelengths shorter than 582 nm enabling an ... most difficult color distinctions. A color anomalous patient ... a color is in the longer or shorter ...
Medicine Products: